CatalystEU/UK

UBS CUTS AMRIZE STOCK PRICE TARGET TO $42 ON WEAK EARNINGS OUTLOOK - INVESTING.COM - GNEWS

UBS cut Amrize price target to $42 citing weak earnings outlook.

What changed

UBS cut Amrize price target to $42 citing weak earnings outlook.

Why it matters

UBS cut Amrize price target to $42 citing weak earnings outlook. — impact context not separately stored; see What changed.

Sources